FIA
LAB icon

FNY Investment Advisers’s Standard BioTools LAB Stock Holding History

FNY Investment Advisers’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,000
Closed -$28K – 811
2022
Q1 		$28K Buy
8,000
+3,000
+60% +$10.4K 0.03% 321
2021
Q4 		$19K Sell
5,000
-13,025
-72% -$61K 0.01% 345
2021
Q3 		$118K Buy
18,025
+2,000
+12% +$13.2K 0.05% 205
2021
Q2 		$98K Sell
16,025
-13,091
-45% -$70K 0.04% 290
2021
Q1 		$131K Buy
29,116
+1,016
+4% +$5.58K 0.05% 260
2020
Q4 		$168K Buy
28,100
+6,100
+28% +$40.1K 0.05% 218
2020
Q3 		$163K Buy
22,000
+12,000
+120% +$82.8K 0.07% 180
2020
Q2 		$40K Buy
+10,000
New +$34.8K 0.02% 218

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FNY Investment Advisers's LAB Position: Q2 2022 in Review

FNY Investment Advisers sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 8,000 shares — an estimated $28K sold.

FNY Investment Advisers first reported a position in LAB in Q2 2020 and held it in 8 quarters. The position peaked at $168K in Q4 2020. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • FNY Investment Advisers reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 8,000 Standard BioTools shares in Q2 2022, an estimated $28K.
  • FNY Investment Advisers first reported a position in Standard BioTools in Q2 2020 and held it in 8 quarters.
  • FNY Investment Advisers's Standard BioTools position peaked at $168K in Q4 2020.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on FNY Investment Advisers's 13F filing for Q2 2022, filed 12 Jul 2022.